Form 4: Baker Bros. Advisors Report Acquisition of IGM Biosciences Stock and Restricted Stock Units

Baker Bros. Advisors and related entities report the acquisition of IGM Biosciences common stock and restricted stock units (RSUs) due to director compensation policies.

Summary

• Baker Bros. Advisors LP, along with related entities and individuals, filed a Form 4 detailing changes in beneficial ownership of IGM Biosciences, Inc. (IGMS) securities.
• The report indicates the acquisition of 1,994 restricted stock units (RSUs) by Felix J. Baker, a managing member of Baker Bros. Advisors (GP) LLC, in lieu of director retainer fees of $11,500.
• These RSUs are fully vested and were issued under IGM Biosciences' Outside Director Compensation Policy.
• The filing also reflects indirect ownership by Baker Bros. entities in a total of 3,759,462 shares of IGM Biosciences common stock.
• Julian C. Baker and Felix J. Baker may be deemed to have an indirect pecuniary interest in the common stock held by 667, L.P. and Baker Brothers Life Sciences, L.P.
• Baker Bros. Advisors LP serves as the investment advisor to the Funds and has complete discretion over the investment and voting power of the securities.
• The reporting persons disclaim beneficial ownership of the securities except to the extent of their pecuniary interest.
• Felix J. Baker is a director of IGM Biosciences, Inc., and the other reporting persons are deemed directors by deputization.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to director compensation and changes in ownership. There's no indication of significant positive or negative news.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future.
• Increased ownership by Baker Bros. entities could be seen as a positive sign by investors.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.

Comparison to Industry Standards

• Director compensation through stock and RSUs is a common practice in the biotech industry to align the interests of directors with those of shareholders.
• Baker Bros. Advisors is a well-known investment firm specializing in life sciences, and their investment decisions are closely watched by the market.

Stakeholder Impact

• The acquisition of RSUs by a director could be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates